Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
Real-time Euronext Amsterdam  -  05/20 04:41:23 am EDT
23.56 EUR   +1.55%
05/17Royal Philips - New release of Philips EchoNavigator helps interventional teams treat structural heart disease with greater ease and efficiency
AQ
05/16Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022
GL
05/16Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Amsterdam
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
23.62(c) 23.91(c) 23.725(c) 23.195(c) 23.555 Last
2 097 720 2 467 269 2 715 931 2 370 686 727 722 Volume
+0.85% +1.23% -0.77% -2.23% +1.55% Change
More quotes
Estimated financial data (e)
Sales 2022 18 272 M 19 345 M 19 345 M
Net income 2022 806 M 853 M 853 M
Net Debt 2022 4 281 M 4 533 M 4 533 M
P/E ratio 2022 24,1x
Yield 2022 3,75%
Sales 2023 19 420 M 20 562 M 20 562 M
Net income 2023 1 399 M 1 482 M 1 482 M
Net Debt 2023 3 996 M 4 231 M 4 231 M
P/E ratio 2023 14,9x
Yield 2023 4,06%
Capitalization 20 163 M 21 348 M 21 348 M
EV / Sales 2022 1,34x
EV / Sales 2023 1,24x
Nbr of Employees 78 189
Free-Float 97,5%
More Financials
Company
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided... 
Read more
More about the company
Ratings of Philips NV
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about PHILIPS NV
05/17Royal Philips - New release of Philips EchoNavigator helps interventional teams treat s..
AQ
05/16Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022
GL
05/16Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022
AQ
05/16New release of Philips EchoNavigator helps interventional teams treat structural heart ..
GL
05/16Koninklijke Philips N.V. Announces the International Launch of EchoNavigator 4.0 at Eur..
CI
05/12PHILIPS NV : Ex-dividend day for final dividend (optional)
FA
05/10Shareholders Vote Down Philips' Executive Compensation Plan
MT
05/10Philips Annual General Meeting of Shareholders approves dividend and other proposals ma..
GL
05/10Royal Philips Approves Appointment of Mrs. Herna Verhagen and Mr. Sanjay Poonen as Memb..
CI
05/10Royal Philips Approves Dividend for the Year 2021
CI
05/10TRANSCRIPT : Koninklijke Philips N.V. - Shareholder/Analyst Call
CI
05/10PHILIPS NV : Press Release
CO
05/09SECTOR UPDATE : Health Care Stocks Decline Premarket Monday
MT
05/09Philips Gets FDA Clearance for New Imaging System
MT
05/09Philips Wins US FDA Approval for New Medical Imaging System
MT
More news
News in other languages on PHILIPS NV
05/17MÄRKTE EUROPA/Durchgreifende Erholung - Daimler Truck stützt
05/17Saxo ziet vertrouwen beleggers dieper wegzakken
05/17Bank of Montreal meldt belang in Philips
05/16Koninklijke Philips N.V. annonce le lancement international d'EchoNavigator 4.0 à EuroP..
05/11Bank of America meldt belang in Philips
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Stock Trading Strategies
PHILIPS NV - 2021
Close to an important medium term support level
BUY
More Stock Trading Analysis
Analysis
European stocks slide to 1-month low on China slowdown fears
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 23,20 €
Average target price 32,18 €
Spread / Average Target 38,7%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Sophie Bechu Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-29.21%21 644
THERMO FISHER SCIENTIFIC-16.88%212 239
DANAHER CORPORATION-25.96%174 392
INTUITIVE SURGICAL, INC.-40.06%77 301
SIEMENS HEALTHINEERS AG-15.38%65 558
EDWARDS LIFESCIENCES CORPORATION-27.90%58 078